Cardiac and peripheral vascular effects of digitalis in clinical cardiogenic shock.
D001794:Blood Pressure / Q000187:drug effects; D002301:Cardiac Glycosides / Q000494:pharmacology*; D002302:Cardiac Output / Q000187:drug effects; D004077:Digoxin / Q000494:pharmacology; D006333:Heart Failure / Q000188:drug therapy*; D006334:Heart Function Tests; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D007263:Infusions, Parenteral; D007799:Lanatosides / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D010042:Ouabain / Q000494:pharmacology; D012769:Shock / Q000188:drug therapy*; D014655:Vascular Resistance / Q000187:drug effects; D014662:Vasoconstrictor Agents / Q000494:pharmacology*
D002301:Cardiac Glycosides; D007799:Lanatosides; D014662:Vasoconstrictor Agents; D010042:Ouabain; D004077:Digoxin